SCHEMBL19882147

SCHEMBL19882147

CCN(Cc1cccc(OC)c1)C(=O)CNC(=O)NCc1ccc(NC)cc1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ TSPO P30536 4/20 0.53
▸ ALDH1A1 P00352 5/20 0.50
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ ROCK2 O75116 2/20 0.47
▸ MEN1 O00255 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ LMNA P02545 1/20 0.46
▸ GAA P10253 1/20 0.46
▸ MAPT P10636 1/20 0.46
▸ ALOX15 P16050 1/20 0.46
▸ GFER P55789 1/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ PPIB P23284 1/20 0.44
▸ MTNR1A P48039 1/20 0.44
▸ MTNR1B P49286 1/20 0.44
▸ HTT P42858 1/20 0.44
▸ MMP13 P45452 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19882131 0.89 PPIB (0.53) TSPOSMN1; SMN2ROCK2MEN1KMT2A
SCHEMBL2038255 0.89 PPIB (0.58) TSPOALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL12643832 0.80 PPIB (0.53) TSPOALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL19882134 0.79 ALDH1A1 (0.45) ALDH1A1SMN1; SMN2MEN1KMT2AHTT
SCHEMBL2040991 0.78 PPIB (0.69) TSPOALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL2038459 0.75 PPIB (0.54) MEN1KMT2ALMNAGAAPPIB
SCHEMBL3815151 0.74 ALDH1A1 (0.72) ALDH1A1SMN1; SMN2ROCK2MEN1KMT2A
SCHEMBL2034561 0.74 PPIB (0.76) ALDH1A1SMN1; SMN2MEN1KMT2ALMNA
SCHEMBL2037882 0.73 PPID (0.69) ALDH1A1SMN1; SMN2MEN1KMT2ALMNA
SCHEMBL16270332 0.71 MEN1 (0.61) ALDH1A1SMN1; SMN2MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2516387-B1 INHIBITORS OF CYCLOPHILINS FOR USE IN THE PREVENTION AND/OR THE TREATMENT OF VIRAL PATHOLOGIES OR INFECTIONS INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECH MÉDICALE (INSERM) (FR) 2018-02-21 — — EP disclosed
Send feedback